SBUX
52
13
SNA
68
2
PLD
56
-2
TROW
59
-3
AKAM
53
2
GME
65
-5
EL
30
-4
VNO
54
-11
EMN
59
3
MOS
50
7
STI
19
-12
PM
66
2
ZTS
49
-5
BXP
55
-4
EXR
64
-2
CA
54
4
PGR
67
2
TGT
31
4
AVY
57
2
LH
46
-2
SBUX
52
13
SNA
68
2
PLD
56
-2
TROW
59
-3
AKAM
53
2
GME
65
-5
EL
30
-4
VNO
54
-11
EMN
59
3
MOS
50
7
STI
19
-12
PM
66
2
ZTS
49
-5
BXP
55
-4
EXR
64
-2
CA
54
4
PGR
67
2
TGT
31
4
AVY
57
2
LH
46
-2
Financhill
Back

First Trust Emerging Markets Eq Sel ETF Vs. Bright Minds Biosciences Industry Stock Comparison

Sell
49

RNEM
First Trust Emerging Markets Eq Sel ETF

Last Price:
51.09
Seasonality Move:
3.52%
Sell
25

DRUG
Bright Minds Biosciences

Last Price:
43.34
Seasonality Move:
-15.89%
Sell
49
First Trust Emerging Markets Eq Sel ETF (RNEM) is a Sell

Is First Trust Emerging Markets Eq Sel ETF a Buy, Sell or Hold?

  • The current First Trust Emerging Markets Eq Sel ETF [RNEM] share price is $51.16. The Score for RNEM is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • RNEM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Bright Minds Biosciences (DRUG) is a Sell

Is Bright Minds Biosciences a Buy, Sell or Hold?

  • The current Bright Minds Biosciences [DRUG] share price is $44.00. The Score for DRUG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RNEM Stock Price Chart

What is First Trust Emerging Markets Eq Sel ETF's stock price today?

  • The First Trust Emerging Markets Eq Sel ETF share price today is $51.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNEM is experiencing buying pressure, which is a positive indicator for future bullish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

  • The Bright Minds Biosciences share price today is $44.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.

RNEM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.47 Sell
Relative Strength Index (14 RSI): 38.75 Sell
Chaikin Money Flow: 652 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.05 - 52.61) Sell
Bollinger Bands (100): (51.83 - 54.15) Sell

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.5 Buy
Relative Strength Index (14 RSI): 58.93 Buy
Chaikin Money Flow: 115403 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.12 - 49.42) Buy
Bollinger Bands (100): (-5.11 - 34.85) Buy

RNEM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 51.29 Sell
20-day SMA: 51.61 Sell
50-day SMA: 53.07 Sell
200-day SMA: 52.47 Sell
8-day EMA: 51.32 Sell
20-day EMA: 51.66 Sell
50-day EMA: 52.4 Sell
200-day EMA: 52.11 Sell

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.17 Buy
20-day SMA: 42.3 Buy
50-day SMA: 28.61 Buy
200-day SMA: 8.06 Buy
8-day EMA: 39.27 Buy
20-day EMA: 39.13 Buy
50-day EMA: 31.07 Buy
200-day EMA: 12.97 Buy

First Trust Emerging Markets Eq Sel ETF Earnings Growth & RNEM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

First Trust Emerging Markets Eq Sel ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):